Fuller & Thaler Asset Management Inc. Sells 43,926 Shares of Bruker Co. (NASDAQ:BRKR)

Fuller & Thaler Asset Management Inc. decreased its stake in Bruker Co. (NASDAQ:BRKR - Free Report) by 11.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 334,534 shares of the medical research company's stock after selling 43,926 shares during the period. Fuller & Thaler Asset Management Inc. owned 0.22% of Bruker worth $19,610,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Barclays PLC raised its stake in shares of Bruker by 36.5% during the 3rd quarter. Barclays PLC now owns 55,685 shares of the medical research company's stock worth $3,847,000 after purchasing an additional 14,888 shares in the last quarter. Retirement Systems of Alabama raised its holdings in shares of Bruker by 11.7% in the 3rd quarter. Retirement Systems of Alabama now owns 134,254 shares of the medical research company's stock valued at $9,272,000 after purchasing an additional 14,069 shares during the period. GAMMA Investing LLC grew its holdings in Bruker by 47.5% during the fourth quarter. GAMMA Investing LLC now owns 1,279 shares of the medical research company's stock worth $75,000 after purchasing an additional 412 shares during the period. Everence Capital Management Inc. acquired a new position in Bruker during the fourth quarter worth approximately $251,000. Finally, Wealth Enhancement Advisory Services LLC raised its stake in Bruker by 1.4% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 13,287 shares of the medical research company's stock valued at $779,000 after buying an additional 177 shares during the period. Institutional investors and hedge funds own 79.52% of the company's stock.

Analyst Ratings Changes

Several research firms have weighed in on BRKR. Stifel Nicolaus lowered their price target on shares of Bruker from $70.00 to $57.00 and set a "hold" rating on the stock in a report on Friday, February 14th. Wells Fargo & Company dropped their price target on Bruker from $75.00 to $60.00 and set an "overweight" rating for the company in a report on Thursday, April 17th. Citigroup decreased their price objective on Bruker from $75.00 to $50.00 and set a "buy" rating on the stock in a report on Monday, April 7th. Barclays dropped their target price on Bruker from $60.00 to $50.00 and set an "overweight" rating for the company in a report on Thursday, April 10th. Finally, Guggenheim restated a "buy" rating on shares of Bruker in a research note on Monday, February 24th. Six research analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $65.00.

Bruker Trading Down 0.3 %

BRKR traded down $0.13 during trading on Wednesday, reaching $39.71. 351,122 shares of the stock traded hands, compared to its average volume of 1,520,521. The company has a quick ratio of 0.77, a current ratio of 1.60 and a debt-to-equity ratio of 1.15. The stock's 50-day moving average is $42.72 and its 200 day moving average is $52.36. Bruker Co. has a 12 month low of $34.10 and a 12 month high of $81.07. The stock has a market capitalization of $6.02 billion, a PE ratio of 52.25, a P/E/G ratio of 2.16 and a beta of 1.18.

Bruker (NASDAQ:BRKR - Get Free Report) last released its quarterly earnings data on Thursday, February 13th. The medical research company reported $0.76 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.75 by $0.01. Bruker had a net margin of 3.36% and a return on equity of 21.01%. Equities analysts anticipate that Bruker Co. will post 2.69 earnings per share for the current year.

Bruker Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 28th. Stockholders of record on Monday, March 17th were paid a $0.05 dividend. This represents a $0.20 annualized dividend and a dividend yield of 0.50%. The ex-dividend date of this dividend was Monday, March 17th. Bruker's dividend payout ratio (DPR) is presently 26.32%.

Bruker Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.